Trial Profile
The Effects of Anti-Viral Therapy on the Clinical Status, Quality of Life, and Survival of Patients With Decompensated Cirrhosis Due to Hepatitis C Genotype 1 Infection
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Ledipasvir/sofosbuvir (Primary)
- Indications Hepatitis C; Liver cirrhosis
- Focus Therapeutic Use
- 23 Oct 2018 Status changed from recruiting to completed.
- 15 Mar 2018 Planned End Date changed from 1 Dec 2018 to 1 Feb 2019.
- 15 Mar 2018 Planned primary completion date changed from 1 Dec 2017 to 1 Dec 2018.